Related references
Note: Only part of the references are listed.Facilitation of Tear Fluid Secretion by 3% Diquafosol Ophthalmic Solution in Normal Human Eyes
Norihiko Yokoi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Douglas G. Day et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Effects of Diquafosol Sodium Eye Drops on Tear Film Stability in Short BUT Type of Dry Eye
Seika Shimazaki-Den et al.
CORNEA (2013)
Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye
Shizuka Koh et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2013)
Effects of Diquafosol Tetrasodium Administration on Visual Function in Short Break-Up Time Dry Eye
Minako Kaido et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
Etsuko Takamura et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Clinical Utility of Objective Tests for Dry Eye Disease: Variability Over Time and Implications for Clinical Trials and Disease Management
Benjamin D. Sullivan et al.
CORNEA (2012)
Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study
K. Kamiya et al.
EYE (2012)
Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study
Shigeru Kinoshita et al.
OPHTHALMOLOGY (2012)
Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
Ingrida Januleviciene et al.
CLINICAL OPHTHALMOLOGY (2012)
Effects of benzalkonium chloride on the ocular surface of the rabbit
Jae Ryun Kim et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2011)
A Comparison of Vitamin A and Cyclosporine A 0.05% Eye Drops for Treatment of Dry Eye Syndrome
Eun Chul Kim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Functions of ocular surface mucins in health and disease
Flavio Mantelli et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: Implications for the pathogenesis of autoimmunity
X Jiang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Pharmacological consequences of oxidative stress in ocular tissues
SE Ohia et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levels
PR Ingram et al.
FREE RADICAL RESEARCH (2004)
Localization of ocular P2Y2 receptor gene expression by in situ hybridization
MS Cowlen et al.
EXPERIMENTAL EYE RESEARCH (2003)
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
D Kellerman et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
INS365 suppresses, epithelial integrity loss of corneal by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model
T Fujihara et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2002)
Effects of common ophthalmic preservatives on ocular health
R Noecker
ADVANCES IN THERAPY (2001)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Share Paper
